ANTIBODIES TO MUTATED CITRULLINATED VIMENTIN (MCV) IN RHEUMATOID ARTHRITIS: CLINICAL AND GENETIC ASSOCIATIONS

被引：0
|
作者：
Charles, Peter J. [1 ]
Poulsom, Hannah [2 ]
Plant, Darren [3 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Healthcare NHS Trust, London, England
[3] Univ Manchester, ARC Epidemiol Unit, Manchester, Lancs, England
来源：
RHEUMATOLOGY | 2009年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I36 / I36
页数：1
相关论文
共 50 条
  • [21] Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
    Al-Shukaili, Ahmed
    Al-Ghafri, Saif
    Al-Marhoobi, Safia
    Alkaabi, Juma
    [J]. INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [22] Subsets of RA patients with an ongoing immune responses determined with isotype distribution of anti mutated citrullinated vimentin (anti-MCV) antibodies in rheumatoid arthritis
    Bang, H.
    Luethke, K.
    Gauliard, A.
    Feist, E.
    Rudolph, Re.
    Fredenhagen, G.
    Egerer, K.
    Berg, W.
    Burmester, G. R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 320 - 321
  • [23] Antibodies directed against mutated citrullinated vimentin (anti-MCV) are more sensitive serological markers of rheumatoid arthritis than anti-CCP
    Lakos, G.
    Soos, L.
    Szabo, Z.
    Fekete, A.
    Zeher, M.
    Horvath, I.
    Danko, K.
    Kapitany, A.
    Szegedi, G.
    Sipka, S.
    Szekanecz, Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 151 - 151
  • [24] Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features
    Reyes-Castillo, Z.
    Palafox-Sanchez, C. A.
    Parra-Rojas, I.
    Martinez-Bonilla, G. E.
    del Toro-Arreola, S.
    Ramirez-Duenas, M. G.
    Ocampo-Bermudes, G.
    Munoz-Valle, Jose F.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (02): : 119 - 131
  • [25] The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
    D Guseinova
    A Lazareva
    R Shantere
    D Berzinja
    O Rasnachs
    V Stanevicha
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
  • [26] Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
    Ishigooka, Nozomi
    Fujii, Takao
    Abe, Hiroyasu
    Murakami, Kosaku
    Nakashima, Ran
    Hashimoto, Motomu
    Yoshifuji, Hajime
    Tanaka, Masao
    Ito, Hiromu
    Ohmura, Koichiro
    Morita, Satoshi
    Mimori, Tsuneyo
    [J]. MODERN RHEUMATOLOGY, 2020, 30 (03) : 450 - 457
  • [27] Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients: Relation to disease activity and manifestations
    El Shazly, Reem Ismail
    Hussein, Somaya Anwar
    Raslan, Hala Zaki
    Elgogary, Amira Ahmed
    [J]. EGYPTIAN RHEUMATOLOGIST, 2014, 36 (02): : 65 - 70
  • [28] DIAGNOSTIC VALUE OF ANTIBODIES AGAINST CITRULLINATED VIMENTIN IN RHEUMATOID ARTHRITIS
    Besada, Emilio
    Nikolaisen, Cathrin
    Nossent, Hans
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 : 28 - 28
  • [29] Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
    Refaat M. El Tanawy
    Khaled M. Belal
    Waleed A. Hassan
    Emtesal A. Said
    Shaimaa M. Hafez
    [J]. Egyptian Rheumatology and Rehabilitation, 2015, 42 (2) : 62 - 67
  • [30] Significance of antibodies against mutated citrullinated vimentin (anti-mcv) in patients with V.a. rheumatoid arthritis in comparison to the rheumatism factors (RF) and anti-CCP antibodies
    Hartung, W
    Weber, E
    Schoelmerich, J
    Fredenhagen, G
    Fleck, M
    [J]. MEDIZINISCHE KLINIK, 2006, 101 (04) : A88 - A88
12345